CARsgen Therapeutics Holdings Ltd. held its annual general meeting on May 22, 2025. During the meeting, several proposals were voted on. The proposal to receive and adopt the audited consolidated financial statements and reports for the year ended December 31, 2024, was approved. The re-election of Mr. Ronggang XIE as a non-executive director was approved. The re-election of Mr. Huaqing GUO as a non-executive director was approved. The re-election of Dr. Guangmei YAN as an independent non-executive director was approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.